Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0000950170-24-025915

EVP, COO acquired 9,167 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lamothe Jeffrey G. EVP, COO 2024-03-02 Option exercise +5,500 33,837 D
Lamothe Jeffrey G. EVP, COO 2024-03-03 Option exercise +3,667 37,504 D
Derivatives
Lamothe Jeffrey G. EVP, COO 2024-03-02 Option exercise · Restricted Stock Unit −5,500 11,000 D
Lamothe Jeffrey G. EVP, COO 2024-03-03 Option exercise · Restricted Stock Unit −3,667 3,667 D
Loading xslF345X05/ownership.xml…